Quanterix (QTRX) SEC Filings: History & Chart

Quanterix Corporation(QTRX)

Medical - Devices · Billerica, MA

$3.50-0.31 (-8.27%)

Delayed quote: Oct 6, 2026, 2:10 PM EDT

About Quanterix Corporation

Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.

Billerica, MA

450 employees

www.quanterix.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Everett V. Cunningham

View full financials

Form	Filing Date	Accepted	Document
4	Oct 2, 2026	Oct 2, 2026	View filing
4	Oct 2, 2026	Oct 2, 2026	View filing
4	Oct 2, 2026	Oct 2, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
S-8	Sep 11, 2026	Sep 10, 2026	View filing
4	Sep 1, 2026	Sep 1, 2026	View filing
4	Aug 20, 2026	Aug 20, 2026	View filing
3	Aug 19, 2026	Aug 19, 2026	View filing
4	Aug 19, 2026	Aug 19, 2026	View filing
4	Aug 17, 2026	Aug 17, 2026	View filing
4	Aug 14, 2026	Aug 14, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
10-Q	Aug 10, 2026	Aug 10, 2026	View filing
8-K	Aug 10, 2026	Aug 10, 2026	View filing
SC 13G	Aug 6, 2026	Aug 6, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 9, 2026	Jul 9, 2026	View filing
4	Jul 9, 2026	Jul 9, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
3	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
3	Jun 12, 2026	Jun 12, 2026	View filing
8-K	Jun 10, 2026	Jun 10, 2026	View filing

SEC Filings

Recent Filings